49 related articles for article (PubMed ID: 38665912)
1. Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study.
Salgado M; Gálvez C; Nijhuis M; Kwon M; Cardozo-Ojeda EF; Badiola J; Gorman MJ; Huyveneers LEP; Urrea V; Bandera A; Jensen BO; Vandekerckhove L; Jurado M; Raj K; Schulze Zur Wiesch J; Bailén R; Eberhard JM; Nabergoj M; Hütter G; Saldaña-Moreno R; Oldford S; Barrett L; Ramirez MLM; Garba S; Gupta RK; Revollo B; Ferra-Coll C; Kuball J; Alter G; Sáez-Cirión A; Diez-Martin JL; Duke ER; Schiffer JT; Wensing A; Martinez-Picado J;
Lancet HIV; 2024 Jun; 11(6):e389-e405. PubMed ID: 38816141
[TBL] [Abstract][Full Text] [Related]
2. True Donor Cell Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: Diagnostic and Therapeutic Considerations-Brief Report.
Hoffmann M; Banz Y; Halter J; Schoumans J; Tchinda J; Bacher U; Pabst T
Curr Oncol; 2024 Apr; 31(4):2067-2075. PubMed ID: 38668056
[TBL] [Abstract][Full Text] [Related]
3. Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation.
Pérez-Simón JA; Caballero D; Diez-Campelo M; Lopez-Pérez R; Mateos G; Cañizo C; Vazquez L; Vidriales B; Mateos MV; Gonzalez M; San Miguel JF
Leukemia; 2002 Aug; 16(8):1423-31. PubMed ID: 12145680
[TBL] [Abstract][Full Text] [Related]
4. [Allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes].
Gournay V; Robin M
Bull Cancer; 2023 Nov; 110(11):1168-1175. PubMed ID: 37516649
[TBL] [Abstract][Full Text] [Related]
5. The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation.
Li Z; Wang J; Deng L; Liu X; Kong F; Zhao Y; Hou Y; Zhou F
Front Immunol; 2024; 15():1382099. PubMed ID: 38665912
[TBL] [Abstract][Full Text] [Related]
6. Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Lee HC; Saliba RM; Rondon G; Chen J; Charafeddine Y; Medeiros LJ; Alatrash G; Andersson BS; Popat U; Kebriaei P; Ciurea S; Oran B; Shpall E; Champlin R
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1948-54. PubMed ID: 26183077
[TBL] [Abstract][Full Text] [Related]
7. Post-transplant cyclophosphamide and early mixed donor Chimerism in myeloid malignancies; a single-center experience.
Hoff FW; Chung SS; Patel PA; Premnath N; Khatib J; Tadic-Ovcina M; AhmedRabie A; Helton D; Yohannes S; Shahan J; Patel H; Geethakumari PR; Vusirikala M; Collins RH; Madanat YF
Transpl Immunol; 2023 Apr; 77():101808. PubMed ID: 36842566
[TBL] [Abstract][Full Text] [Related]
8. Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
Jiang Y; Wan L; Qin Y; Wang X; Yan S; Xie K; Wang C
PLoS One; 2015; 10(7):e0133671. PubMed ID: 26226104
[TBL] [Abstract][Full Text] [Related]
9. Quantitative chimerism kinetics in relapsed leukemia patients after allogeneic hematopoietic stem cell transplantation.
Qin XY; Li GX; Qin YZ; Wang Y; Wang FR; Liu DH; Xu LP; Chen H; Han W; Wang JZ; Zhang XH; Li JL; Li LD; Liu KY; Huang XJ
Chin Med J (Engl); 2012 Jun; 125(11):1952-9. PubMed ID: 22884060
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
11. Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation.
Kanaan SB; Urselli F; Radich JP; Nelson JL
Blood Adv; 2023 Oct; 7(20):6066-6079. PubMed ID: 37467017
[TBL] [Abstract][Full Text] [Related]
12. Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS.
Loke J; McCarthy N; Jackson A; Siddique S; Hodgkinson A; Mason J; Crawley C; Gilleece M; Peniket A; Protheroe R; Salim R; Tholouli E; Wilson K; Andrew G; Dillon R; Khan N; Potter V; Krishnamurthy P; Craddock C; Freeman S
Blood Adv; 2023 Jul; 7(14):3666-3676. PubMed ID: 37058448
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of T-cell-suppressive PD-L1
Baur R; Karl F; Böttcher-Loschinski R; Stoll A; Völkl S; Gießl A; Flamann C; Bruns H; Schlötzer-Schrehardt U; Böttcher M; Schewe DM; Fischer T; Jitschin R; Mackensen A; Mougiakakos D
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36898735
[TBL] [Abstract][Full Text] [Related]
14. Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial.
Zhang H; Fan Z; Huang F; Han L; Xu Y; Xu N; Deng L; Wang S; Lin D; Luo X; Zhang Q; Liu X; Li X; Liang X; Xie S; Qu H; Yu S; Zhou H; Shi P; Xuan L; Lin R; Liu H; Jin H; Sun J; Liu Q
J Clin Oncol; 2023 Jan; 41(2):343-353. PubMed ID: 36084276
[TBL] [Abstract][Full Text] [Related]
15. The mythological chimera and new era of relapse prediction post-transplant.
Ciurea SO; Kothari A; Sana S; Al Malki MM
Blood Rev; 2023 Jan; 57():100997. PubMed ID: 35961800
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
